Brief: SenesTech Inc Says Has Been Working With TriptoBIO On Development Of Biosynthetic Triptolide
14/03/2023 13:20
March 14 (Reuters) - SenesTech Inc SNES.O :
* SENESTECH INC - HAS BEEN WORKING WITH TRIPTOBIO ON
DEVELOPMENT
OF BIOSYNTHETIC TRIPTOLIDE, ONE OF ACTIVE INGREDIENTS IN
CONTRAPEST
Source text for Eikon: ID:nPn3TZBMma
Further company coverage: SNES.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SenesTech
See all newsSenesTech Q1 revenue up, loss widens on severance, legal costs
Brief: Senestech Appoints Michael Edell As President And Chief Executive Officer To Drive Revenue Growth And Scalable Sales Channels
SenesTech 2025 revenue rises 20% on e-commerce growth
Brief: SenesTech Q4 Revenue USD 421 Thousand
Brief: Senestech Inc - Joel L. Fruendt, President & CEO Of Co To Retire